WALL, N.J., June 1 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based
Oklahoma Blood Institute (OBI), the twelfth largest non-profit regional blood center in America is incorporating BIO-key's patented fingerprint identification solution to provide blood donors with a fast and convenient method to establish their identity. This solution automates the donor check in process and protects donor privacy by eliminating the need for donors to produce sensitive identification forms, such as driver licenses or social security numbers. With just the simple touch of the donor's finger the software can search the OBI database to provide positive ID, reducing the check-in time and virtually eliminating human errors during the check-in process.
"At OBI, we recognize the importance of providing convenience for our donors and protecting their identity. Using the BIO-key ID solution, we are able to protect our donor's privacy while reducing the chance of duplicate donor IDs and aliases in our system," said John Armitage, M.D., Oklahoma Blood Institute president and chief executive. "We are constantly looking for ways to improve our donors' experiences and protect the integrity of the blood supply for Oklahomans."
"One of the key features that led to OBI choosing BIO-key's TruDonor identity solution is its ability to search the OBI database to positively identify a donor with the simple touch of a finger, without the need for other forms of identification or manual lookup," said Jim Sullivan, BIO-key International's Sales Director. "Another feature that differentiates us from other biometric identity solutions is our fingerprint reader independence. This enables enrollment, identification and verification to be performed by fingerprint scanners produced by any of the major fingerprint reader manufacturers. So popular laptops, tablet PCs, workstation keyboards and even cell phones that have integrated fingerprint readers can be used to establish the donor's ID."
Oklahoma Blood Institute provides every drop of blood needed by patients in more than 150 medical facilities in Oklahoma and north central Texas with the help of nearly 700 employees working with as many as 800 volunteers and 2,600 drive coordinators. In addition to its headquarters and laboratories, donor centers are located in the Oklahoma City-area, Tulsa, Lawton, Enid, Ardmore, Ada and Ponca City. OBI also operates the Texas Blood Institute in Wichita Falls.
"This is the first major deployment that is the result of close collaboration with our partner Healthcare-ID, a leading solution provider to the Blood Center Industry," added Mike DePasquale, President & CEO of BIO-key International. Healthcare-ID provides solutions that automate the entry of accurate information at both fixed and mobile collection sites to eliminate disposal of collected blood units based on donor eligibility and suitability and significantly reduce the cost of blood collection.
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
SOURCE BIO-key International, Inc.
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All